Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2007 1
2008 3
2009 3
2010 4
2011 2
2012 9
2013 9
2014 7
2015 14
2016 9
2017 12
2018 10
2019 14
2020 15
2021 14
2022 19
2023 4
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 32513905

134 results
Results by year
Filters applied: . Clear all
Page 1
The value of [11C]-acetate PET and [18F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab.
Li S, Peck-Radosavljevic M, Ubl P, Wadsak W, Mitterhauser M, Rainer E, Pinter M, Wang H, Nanoff C, Kaczirek K, Haug A, Hacker M. Li S, et al. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1732-1741. doi: 10.1007/s00259-017-3724-2. Epub 2017 May 29. Eur J Nucl Med Mol Imaging. 2017. PMID: 28555333 Free PMC article.
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy.
Contractor K, Challapalli A, Tomasi G, Rosso L, Wasan H, Stebbing J, Kenny L, Mangar S, Riddle P, Palmieri C, Al-Nahhas A, Sharma R, Turkheimer F, Coombes RC, Aboagye E. Contractor K, et al. Phys Med Biol. 2012 Jun 7;57(11):3419-33. doi: 10.1088/0031-9155/57/11/3419. Epub 2012 May 10. Phys Med Biol. 2012. PMID: 22572708 Clinical Trial.
Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K, Numata K, Morimoto M, Kondo M, Nozaki A, Moriya S, Ishii T, Oshima T, Fukuda H, Okada M, Takebayashi S, Maeda S, Tanaka K. Takizawa K, et al. Eur J Radiol. 2013 Sep;82(9):1471-80. doi: 10.1016/j.ejrad.2013.04.045. Epub 2013 Jun 13. Eur J Radiol. 2013. PMID: 23769188 Clinical Trial.
Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.
Cascales-Campos PA, Ramírez P, Lopez V, Gonzalez R, Saenz-Mateos L, Llacer E, Sánchez Bueno F, Robles R, Pons JA, Capel A, Frutos L, Navarro JL, Muñoz-Ramon P, Parrilla P. Cascales-Campos PA, et al. Transplant Proc. 2015 Oct;47(8):2374-6. doi: 10.1016/j.transproceed.2015.08.026. Transplant Proc. 2015. PMID: 26518931
134 results